Letters to the Editor
Published in:
Volume 5 / Year 2016 / Issue 1
Volume 5 / Year 2016 / Issue 1
First biosimilar of infliximab approved in Brazil: response from the Brazilian IBD society
Author(s): Professor Fabio V Teixeira, MSc, MD, PhD
Page: 4-5
Page: 4-5
Abstract: CT-P13 was the first infliximab biosimilar approved in Brazil. Approval was granted for all indications of the innovator. Despite similar efficacy and safety, vigilance remains essential. Submitted: 4 January… Read More »